Floatz logo

Star0602

Abdominal Neoplasm

Marengo Therapeutics, Inc.Phase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Abdominal Neoplasm cohort.

Asset / SponsorPhaseRating
Bxcl501
Medical College of Wisconsin
Phase 4BB
LIDOCAINE
Medical College of Wisconsin
Phase 4BB
PROPOFOL
Medical College of Wisconsin
Phase 4BB
Glycopyrrolate
Medical College of Wisconsin
Phase 4BB
DINITROGEN MONOXIDE
Medical College of Wisconsin
Phase 4BB

View all 11 →

Same molecule, other indications

Star0602 is also rated in:

breast cancerDormant
CCC
Indicative ·
48 / 100
View asset →
triple-negative breast carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
female reproductive system neoplasmDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →